Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR6 | P50406 | 2/20 | 0.38 |
| ▸ | CHRNB2 | P17787 | 2/20 | 0.38 |
| ▸ | CHRNA4 | P43681 | 2/20 | 0.38 |
| ▸ | IDO1 | P14902 | 1/20 | 0.38 |
| ▸ | HRH3 | Q9Y5N1 | 3/20 | 0.37 |
| ▸ | HRH4 | Q9H3N8 | 2/20 | 0.37 |
| ▸ | HTR1A | P08908 | 4/20 | 0.36 |
| ▸ | LATS1 | O95835 | 1/20 | 0.34 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.34 |
| ▸ | HTR1D | P28221 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | GLI1 | P08151 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | MPO | P05164 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18541478 | 0.79 | CHRNB2 (0.41) | HTR6CHRNB2CHRNA4HTR1ALATS1 | |
| SCHEMBL10843139 | 0.78 | SLC6A2 (0.41) | HTR6CHRNB2CHRNA4ALDH1A1GLI1 | |
| SCHEMBL31415245 | 0.78 | SLC6A2 (0.41) | HTR6CHRNB2CHRNA4ALDH1A1GLI1 | |
| SCHEMBL7402425 | 0.75 | POLB (0.34) | HTR6CHRNB2CHRNA4CHRNA7ALDH1A1 | |
| SCHEMBL7398048 | 0.73 | CHRM5 (0.37) | HTR6CHRNB2CHRNA4ALDH1A1GLI1 | |
| SCHEMBL22551888 | 0.73 | AOC3 (0.48) | CHRNB2CHRNA4CYP2D6 | |
| SCHEMBL3083326 | 0.70 | KDM4C (0.42) | HTR6IDO1ALDH1A1 | |
| SCHEMBL18542834 | 0.69 | CHRNB2 (0.34) | CHRNB2CHRNA4LATS1 | |
| SCHEMBL3031908 | 0.69 | LOXL2 (0.46) | HRH3HTR1AALDH1A1CYP3A4CYP2D6 | |
| SCHEMBL28223638 | 0.68 | CYP11B1 (0.42) | CHRNB2CHRNA4CHRNA7ALDH1A1GLI1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240210824-A1 | CARBOXYLATE, CARBOXYLIC ACID GENERATOR, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2024-06-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240210824-A1 | CARBOXYLATE, CARBOXYLIC ACID GENERATOR, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN | SCO2, CBR1, OXGR1 | HTR6 4196/4885CHRNB2 1817/4885CHRNA4 393/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.